SPECCHIA, Giorgina
 Distribuzione geografica
Continente #
NA - Nord America 26.803
EU - Europa 10.503
AS - Asia 9.480
SA - Sud America 2.620
Continente sconosciuto - Info sul continente non disponibili 925
AF - Africa 527
OC - Oceania 15
Totale 50.873
Nazione #
US - Stati Uniti d'America 26.365
SG - Singapore 3.835
IT - Italia 2.668
CN - Cina 2.215
DE - Germania 2.093
BR - Brasile 2.044
RU - Federazione Russa 1.874
HK - Hong Kong 1.189
SE - Svezia 1.098
GB - Regno Unito 644
VN - Vietnam 632
FR - Francia 578
FI - Finlandia 546
UA - Ucraina 439
IN - India 322
BD - Bangladesh 275
CA - Canada 202
AR - Argentina 198
CI - Costa d'Avorio 170
ID - Indonesia 124
IQ - Iraq 122
MX - Messico 113
ZA - Sudafrica 113
TR - Turchia 103
CO - Colombia 89
PK - Pakistan 87
PL - Polonia 86
EC - Ecuador 74
BE - Belgio 73
IE - Irlanda 73
VE - Venezuela 70
JP - Giappone 68
SA - Arabia Saudita 66
UZ - Uzbekistan 62
PH - Filippine 61
NL - Olanda 57
MA - Marocco 55
ES - Italia 51
CL - Cile 42
AT - Austria 37
MY - Malesia 36
PY - Paraguay 36
TN - Tunisia 35
CZ - Repubblica Ceca 31
JM - Giamaica 31
JO - Giordania 30
KE - Kenya 30
NP - Nepal 28
LT - Lituania 27
KR - Corea 26
PE - Perù 26
EG - Egitto 24
UY - Uruguay 22
IL - Israele 21
DZ - Algeria 20
ET - Etiopia 20
KZ - Kazakistan 20
OM - Oman 20
CR - Costa Rica 19
RO - Romania 18
AE - Emirati Arabi Uniti 17
IR - Iran 16
TH - Thailandia 16
AZ - Azerbaigian 15
CH - Svizzera 15
AU - Australia 13
RS - Serbia 13
BO - Bolivia 11
HN - Honduras 11
SN - Senegal 11
BY - Bielorussia 10
GT - Guatemala 10
PA - Panama 10
PT - Portogallo 10
TT - Trinidad e Tobago 10
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
HU - Ungheria 8
LB - Libano 8
TW - Taiwan 7
AO - Angola 6
BG - Bulgaria 6
BS - Bahamas 6
EU - Europa 6
GE - Georgia 6
KG - Kirghizistan 6
NI - Nicaragua 6
BH - Bahrain 5
EE - Estonia 5
GR - Grecia 5
HR - Croazia 5
KW - Kuwait 5
MD - Moldavia 5
SC - Seychelles 5
AL - Albania 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BN - Brunei Darussalam 4
KH - Cambogia 4
Totale 49.862
Città #
Fairfield 3.138
Ashburn 2.613
Singapore 2.053
Woodbridge 2.047
Houston 1.578
Chandler 1.572
San Jose 1.419
Seattle 1.334
Hong Kong 1.182
Cambridge 1.130
Wilmington 1.034
Ann Arbor 987
Jacksonville 986
Milan 920
Nyköping 853
Beijing 634
Council Bluffs 555
New York 548
Los Angeles 403
Lawrence 378
Roxbury 375
Lauterbourg 365
Rome 323
Nanjing 291
Dallas 286
Bari 268
Des Moines 255
Boardman 237
Ho Chi Minh City 209
Helsinki 207
Munich 171
Abidjan 169
São Paulo 167
Santa Clara 166
Princeton 164
San Diego 156
Brooklyn 155
Inglewood 135
Hanoi 124
Buffalo 121
Columbus 113
Moscow 99
Chicago 95
Shenyang 92
London 90
Hebei 89
Nanchang 89
Falkenstein 87
Dearborn 80
Figino 73
Brussels 71
Frankfurt am Main 71
Dublin 68
Jakarta 68
Jiaxing 68
Johannesburg 63
Tianjin 63
Rio de Janeiro 62
Warsaw 62
Changsha 61
Redwood City 61
Pune 60
Tashkent 57
Atlanta 55
Baghdad 55
Denver 55
Montreal 55
Phoenix 54
Tokyo 53
Turin 53
Chennai 51
Paris 51
Belo Horizonte 49
Toronto 44
San Francisco 43
Turku 43
Nuremberg 42
The Dalles 42
Guangzhou 40
Naples 40
Brasília 39
Orem 39
Marseille 38
Dong Ket 37
Shanghai 36
Curitiba 35
Mexico City 34
Dhaka 32
Medellín 31
Boston 29
Florence 29
Lahore 29
Quito 29
Guayaquil 28
Porto Alegre 28
Jeddah 27
Stockholm 27
Haiphong 26
Jinan 26
Ankara 25
Totale 32.899
Nome #
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia 743
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 259
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 255
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 238
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 227
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 225
Monosomal karyotype in myeloid neoplasias: a literature review 225
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 215
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 215
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 214
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 211
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 206
Isolation and characterization of neural stem cells from dystrophic mdx mouse 206
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 204
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 203
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 203
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 201
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 199
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 199
A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow 197
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 197
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma 197
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 196
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 196
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 190
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 189
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 189
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 187
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 186
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 185
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 185
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 184
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 183
Cardiovascular events and intensity of treatment in polycythemia vera. 183
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 179
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 178
Non-treatment-related chronic myeloid leukemia as a second malignancy 177
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 175
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 173
Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic Telangiectasia 172
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 172
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 172
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 172
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 172
Decreased TET2 gene expression during chronic myeloid leukemia progression 171
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 168
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 168
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 167
CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) 167
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 165
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 163
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 163
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 163
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 162
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 162
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 160
ANALYSIS OF PROGNOSTIC FACTORS AND TIME TO FIRST TREATMENT IN YOUNG PATIENTS (<55 YEARS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTER EXPERIENCE 160
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 160
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 159
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 157
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 157
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 157
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 156
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 156
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 155
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 154
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 154
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 153
Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature 153
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 153
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 152
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 151
Typhlitis complicating induction therapy in adult acute myeloid leukemia 151
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 151
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 149
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 148
DARA-VD VERSUS DARA-RD AS SALVAGE THERAPY FOR PATIENTS WITH MYELOMA. INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY RETE EMATOLOGICA PUGLIESE 148
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia 148
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 147
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 147
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 147
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 147
A rare case of IgM-Multiple Myeloma 145
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 145
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients 145
Autoimmune Myelofibrosis: report of three cases and review of the literature 143
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 143
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 142
The role of multiparameter flow cytometry in the work-up of IGM-monoclonal gammopathies 142
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia 141
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 141
A case of light chain (AL) amyloidosis associated with IgD Multiple Myeloma (MM): clinical features, laboratory findings and outcome 141
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 140
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 140
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 140
Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice 140
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 139
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 139
A novel translocation t(1;7) (p36;q34) in three patients with acute myeloid leukaemia 138
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 138
Totale 17.725
Categoria #
all - tutte 198.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.218 0 0 26 89 126 258 129 123 207 218 449 593
2022/20234.152 611 496 252 349 480 587 42 462 684 31 76 82
2023/20241.760 160 277 73 88 181 596 32 49 9 62 28 205
2024/20256.614 192 123 538 273 178 576 616 597 299 392 940 1.890
2025/202615.597 1.987 660 987 1.798 1.669 822 1.528 419 2.157 1.383 449 1.738
2026/20271.784 421 756 607 0 0 0 0 0 0 0 0 0
Totale 50.873